IMPORTANT NOTE: Both the children mentioned below had their samples stored in BioVault storage facility U.K. and are two out of more than 2200 samples successfully made available by BioVault for use for various procedures around the Globe. We wish Sasha and Ahmed full and fruitful lives.
Three UAE cord blood samples processed and stored by BioVault have been used to good effect. Two samples were used to treat Thalassemia and the third for Cerebral Palsy.
Seven year old Ahmed Mohammad’s success story is very much in the public domain and touched a large number of local and international readers . Ahmed hails from Fujairah and was treated in Germany. The process involved destroying his bone marrow first through chemotherapy. Next he was given cord blood from his healthy sister Alanoud to replace the bone marrow. The transplant was a complete success and he is now cured. He no longer needs problematic life saving transfusions and chelation therapy.
Sasha Browne’s story is no less remarkable, a Dubai resident but treated half way around the world in North Carolina. She is among the first beneficiaries of the Duke University’s study on Cerebral Palsy that is creating quite a lot of interest in the international press. Unlike Ahmed, Sasha received her own cord blood through infusion. Her story is one of hope for millions of sufferers of Cerebral Palsy.
BioVault was awarded JACIE accreditation in November 2011, an extremely proud achievement for us as we are the first private tissue bank to be awarded this accreditation in the UK. JACIE The Joint Accreditation Committee-ISCT & EBMT is a non profit body established in 1998 for the purposes of assessment and accreditation in the field of haematopoietic stem cell (HSC) transplantation.
BioVault holds an open ended, unconditional HTA licence which covers every aspect of all transplantable material for human application. For more detail concerning BioVault's HTA licence
(licence no: 11063)
The internationally recognised standard for an organisation's internal Quality Management.
(certificate no: GB04/62552)
Quality management standards for medical devices
(certificate no: GB07/72849)
BioVault's Flow Cytometers are externally quality controlled by NEQAS .
British Association of Tissue Banks
BioVault is an established member of the British Association of Tissue Banks
Biovault has also recently become a member of the ESBB, European, Middle Easter and African Society for Biopreservation and Biobanking. The mission of the ESBB is to advance the field of biobanking in support of research relating to healthcare, education and the environment.
Biovault has been issued the Certificate of Registration for the Community Trade Mark as of 24.12.2009 by The Office of Harmonization for the Internal Market. This is valid in all 27 countries of the EU.
Please find below few selected quotes from the final 'site visit inspection' report of 15 May 2012 by HTA. http://www.hta.gov.uk/_db/_documents/2012-03-07_11063.pdf
"Compliance with HTA standards"
"All applicable HTA standards have been assessed as fully met."
"The DI and CLHC have a good understanding of regulatory requirements. Staff at the establishment demonstrate a strong commitment to meeting HTA requirements and to the ongoing development of a culture of continuous improvement."
Records are owned by BioVault but are held in a fully-serviced commercial data centre under a commercial contract.
Records are multi-backed-up the system is resilient, robust, fast and infinitely expandable.
Record storage is full pre-paid for a 55 year period and access is guaranteed.
BioVault operates a fully compliant records system.
Future storage charges are escrowed and drawn down annually. The funds are controlled by an independent professional and not implicated should BioVault cease to exist and hence available for future storage.